AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Research | Open Access

Experience of diagnosis and managements for patients with primary progressive freezing of gait

Department of Neurology, Shanghai General Hospital Jiading Branch, Shanghai Jiao-Tong University School of Medicine, Shanghai 201812, China
Department of Neurology, Affiliated Hospital of Jiangnan University, Wuxi 214000, Jiangsu, China
Graduate School, Nanjing Medical University, Nanjing 211166, Jiangsu, China
Department of Geriatrics, Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210046, Jiangsu, China

1 These authors contributed equally to this work.

Show Author Information

Abstract

Objective

The goal of this research was to evaluate the clinical characteristics of patients with primary progressive freezing of gait (PPFOG).

Patients and methods

This retrospective study enrolled 8 PPFOG patients and 10 age-matched Parkinson's disease with freezing of gait (PDFOG) patients. All patients underwent structured forms to document clinical manifestations and neuropsychological evaluations.

Result

PPFOG patients demonstrated later onset age than PDFOG patients (70.00 ± 9.97 years versus 53.30 ± 5.40 years, respectively; P < 0.05). Besides FOG (100%), the most prevalent concomitant symptoms of PPFOG patients were falling (n = 6, 75%), and fatigue (n = 5, 62.5%). More PPFOG patients had cerebrovascular risk factors and mild brain magnetic resonance imaging (MRI) abnormalities, which were constant with the manifestations of "cerebral small vessel disease" (P = 0.0001).

Conclusion

According to this study, the majority of PPFOG patients were linked with cerebrovascular disease risk factors and mild brain MRI abnormalities. More research on larger populations is needed to better understand the potential mechanisms underlying the link between PPFOG and cerebral small vessel disease.

References

1

Shine JM, Naismith SL, Lewis SJG. The differential yet concurrent contributions of motor, cognitive and affective disturbance to freezing of gait in Parkinson's disease. Clin Neurol Neurosurg. 2013;115(5): 542-545.

2

Weiss D, Schoellmann A, Fox MD, et al. Freezing of gait: understanding the complexity of an enigmatic phenomenon. Brain. 2020;143(1): 14-30.

3

Giladi N, Kao R, Fahn S. Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord. 1997;12(3): 302-305.

4

Achiron A, Ziv I, Goren M, et al. Primary progressive freezing gait. Mov Disord. 1993;8(3): 293-297.

5

Factor SA, Jennings DL, Molho ES, et al. The natural history of the syndrome of primary progressive freezing gait. Arch Neurol. 2002;59(11): 1778-1783.

6

Factor SA, Higgins DS, Qian J. Primary progressive freezing gait: a syndrome with many causes. Neurology. 2006;66(3): 411-413.

7

Nonnekes J, Snijders AH, Nutt JG, et al. Freezing of gait: a practical approach to management. Lancet Neurol. 2015;14(7): 768-778.

8

Sawada M, Wada-Isoe K, Hanajima R, et al. Clinical features of freezing of gait in Parkinson's disease patients. Brain Behav. 2019;9(4), e01244.

9

Salsone M, Bagnato A, Novellino F, et al. Cardiac MIBG scintigraphy in primary progressive freezing gait. Park Relat Disord. 2009;15(5): 365-369.

10

Silberstein P, Bittar RG, Boyle R, et al. Deep brain stimulation for Parkinson's disease: Australian referral guidelines. J Clin Neurosci. 2009;16(8): 1001-1008.

11

Zhang LL, Canning SD, Wang XP. Freezing of gait in Parkinsonism and its potential drug treatment. Curr Neuropharmacol. 2016;14(4): 302-306.

12

Kim R, Kim HJ, Shin C, et al. Long-term effect of subthalamic nucleus deep brain stimulation on freezing of gait in Parkinson's disease. J Neurosurg. 2019;131(6): 1797-1804.

13

Ostrem JL, Christine CW, Glass GA, et al. Pedunculopontine nucleus deep brain stimulation in a patient with primary progressive freezing gait disorder. Stereotact Funct Neurosurg. 2010;88(1): 51-55.

14

Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3): 181-184.

15

León Ruiz M, García-Soldevilla MÁ, García-Albea Ristol E. Primary progressive freezing gait with impressive response to laser light visual cueing: a video case report. J Neurol. 2018;265(9): 2146-2148.

16

Fasano A, Baldari S, di Giuda D, et al. Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis. Park Relat Disord. 2012;18(5): 578-584.

17

Williams DR, Holton JL, Strand K, et al. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord. 2007;22(15): 2235-2241.

18

Perez-Lloret S, Negre-Pages L, Damier P, et al. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. JAMA Neurol. 2014;71(7): 884-890.

19

Müller J, Seppi K, Stefanova N, et al. Freezing of gait in postmortem-confirmed atypical Parkinsonism. Mov Disord. 2002;17(5): 1041-1045.

20

Grażyńska A, Urbaś W, Antoniuk S, et al. Comparative analysis of non-motor symptoms in patients with Parkinson's Disease and atypical parkinsonisms. Clin Neurol Neurosurg. 2020;197, 106088.

21

Zúñiga C, Lester J, Cersósimo MG, et al. Treatment of primary progressive freezing of gait with high doses of selegiline. Clin Neuropharmacol. 2006;29(1): 20-21.

22

Coria F, Cozar-Santiago MD. Rasagiline improves freezing in a patient with primary progressive freezing gait. Mov Disord. 2008;23(3): 449-451.

23

Kim YE, Yun JY, Yang HJ, et al. Amantadine induced corneal edema in a patient with primary progressive freezing of gait. J Mov Disord. 2013;6(2): 34-36.

24

Delgado-Alvarado M, Marano M, Santurtún A, et al. Nonpharmacological, nonsurgical treatments for freezing of gait in Parkinson's disease: a systematic review. Mov Disord. 2020;35(2): 204-214.

25

Yu KJ, Ren ZW, Guo S, et al. Effects of pedunculopontine nucleus deep brain stimulation on gait disorders in Parkinson's Disease: a meta-analysis of the literature. Clin Neurol Neurosurg. 2020;198, 106108.

26

Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8): 822-838.

27

Finsterwalder S, Vlegels N, Gesierich B, et al. Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients. Alzheimers Dement. 2020;16(11): 1504-1514.

28

Ter Telgte A, van Leijsen EMC, Wiegertjes K, et al. Cerebral small vessel disease: from a focal to a global perspective. Nat Rev Neurol. 2018;14(7): 387-398.

29

Kim YJ, Kwon HK, Lee JM, et al. Gray and white matter changes linking cerebral small vessel disease to gait disturbances. Neurology. 2016;86(13): 1199-1207.

30

Zhang LL, Canning SD, Wang XP. Freezing of gait in Parkinsonism and its potential drug treatment. Curr Neuropharmacol. 2016;14(4): 302-306.

31

Cao SS, Yuan XZ, Wang SH, et al. Transverse strips instead of wearable laser lights alleviate the sequence effect toward a destination in Parkinson's disease patients with freezing of gait. Front Neurol. 2020;11: 838.

32

Huang CY, Chu HL, Zhang Y, et al. Deep brain stimulation to alleviate freezing of gait and cognitive dysfunction in Parkinson's disease: update on current research and future perspectives. Front Neurosci. 2018;12: 29.

Journal of Neurorestoratology
Article number: 100039
Cite this article:
Zhang L-L, Zhao Y-J, Zhang L, et al. Experience of diagnosis and managements for patients with primary progressive freezing of gait. Journal of Neurorestoratology, 2023, 11(1): 100039. https://doi.org/10.1016/j.jnrt.2022.100039

496

Views

1

Crossref

1

Web of Science

1

Scopus

Altmetrics

Received: 11 August 2022
Revised: 05 November 2022
Accepted: 27 November 2022
Published: 09 December 2022
© 2022 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return